1.
Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia--meta-analysis
of 41 robust inception cohort studies. Acta psychiatrica Scandinavica 2009, 119(4):252-65.
2.
Attems J, Jellinger KA. Olfactory tau pathology in Alzheimer disease and mild cognitive
impairment. Clinical neuropathology 2006, 25(6):265-71.
3.
Freitas S, Simoes MR, Alves L, et al. Montreal cognitive assessment: validation study for mild cognitive impairment and
Alzheimer disease. Alzheimer disease and associated disorders 2013, 27(1):37-43.
4.
Freitas S, Simoes MR, Alves L, et al. Montreal Cognitive Assessment: influence of sociodemographic and health variables.
Archives of clinical neuropsychology : the official journal of the National Academy
of Neuropsychologists 2012, 27(2):165-75.
5.
Hu JB, Zhou WH, Hu SH, et al. Cross-cultural difference and validation of the Chinese version of Montreal Cognitive
Assessment in older adults residing in Eastern China: preliminary findings. Archives
of gerontology and geriatrics 2013, 56(1):38-43.
6.
Bosco A, Spano G, Caffo AO, et al. Italians do it worse. Montreal Cognitive Assessment (MoCA) optimal cut-off scores
for people with probable Alzheimer's disease and with probable cognitive impairment.
Aging clinical and experimental research 2017, 29(6):1113-20.
7.
Ng A, Chew I, Narasimhalu K, et al. Effectiveness of Montreal Cognitive Assessment for the diagnosis of mild cognitive
impairment and mild Alzheimer's disease in Singapore. Singapore medical journal 2013,
54(11):616-9.
8.
Pugh EA, Kemp EC, van Dyck CH, et al. Effects of Normative Adjustments to the Montreal Cognitive Assessment. The American
journal of geriatric psychiatry : official journal of the American Association for
Geriatric Psychiatry 2018, 26(12):1258-67.
9.
Milani SA, Marsiske M, Cottler LB, et al. Optimal cutoffs for the Montreal Cognitive Assessment vary by race and ethnicity.
Alzheimer's & dementia (Amsterdam, Netherlands) 2018, 10:773-81.
10.
Chen KL, Xu Y, Chu AQ, et al. Validation of the Chinese Version of Montreal Cognitive Assessment Basic for Screening
Mild Cognitive Impairment. Journal of the American Geriatrics Society 2016, 64(12):e285-e90.
11.
Huang L, Chen KL, Lin BY, et al. Chinese version of Montreal Cognitive Assessment Basic for discrimination among
different severities of Alzheimer's disease. Neuropsychiatric disease and treatment
2018, 14:2133-40.
12.
Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Archives of neurology
1999, 56(3):303-8.
13.
Zhang MY, Katzman R, Salmon D, et al. The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of
age, gender, and education. Annals of neurology 1990, 27(4):428-37.
14.
Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules.
Neurology 1993, 43(11):2412-4.
15.
Jack CR, Jr., Albert MS, Knopman DS, et al. Introduction to the recommendations from the National Institute on Aging-Alzheimer's
Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's
& dementia : the journal of the Alzheimer's Association 2011, 7(3):257-62.
16.
Gates N, Valenzuela M. Cognitive exercise and its role in cognitive function in older
adults. Current psychiatry reports 2010, 12(1):20-7.
17.
Clement F, Gauthier S, Belleville S. Executive functions in mild cognitive impairment:
emergence and breakdown of neural plasticity. Cortex; a journal devoted to the study
of the nervous system and behavior 2013, 49(5):1268-79.
18.
Saunders NL, Summers MJ. Longitudinal deficits to attention, executive, and working
memory in subtypes of mild cognitive impairment. Neuropsychology 2011, 25(2):237-48.